MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway

BACKGROUND: Trastuzumab resistance is almost inevitable in the management of human epidermal growth factor receptor (HER) 2 positive breast cancer, in which phosphatase and tensin homolog deleted from chromosome 10 (PTEN) loss is implicated. Since metadherin (MTDH) promotes malignant phenotype of br...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Cheng, Yi, Xiaomin, Liu, Wenchao, Han, Tao, Liu, Zhaozhe, Ding, Zhenyu, Zheng, Zhendong, Piao, Ying, Yuan, Jianlin, Han, Yaling, Xie, Manjiang, Xie, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254009/
https://www.ncbi.nlm.nih.gov/pubmed/25417825
http://dx.doi.org/10.1186/1471-2407-14-869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254009/
https://www.ncbi.nlm.nih.gov/pubmed/25417825
http://dx.doi.org/10.1186/1471-2407-14-869

Ejemplares similares